Pharma News

A share listed companies in the first three quarters of the performance forecast has come out, a number of pharmaceutical biological companies' performance "pre-pleased".

• Biotech
• Biochem

Patient-friendly products such as prepared syringes and automated delivery platforms are increasingly dominating the injectable packaging and delivery industry as the healthcare industry innovates in drug development, continues to focus on drug safety.

• Western pharmaceutical packaging

Novo Nordisk announced its insulin icodec 1 times a week in a ONWARDS 5 stage IIIa clinical trials for top line positive results.

• Novo Nordisk
• Icodec
• ONWARDS 5

Bojian and Eisai jointly announced that lecanemab, an ongoing Alzheimer's disease (AD) treatment jointly developed by the two companies, met the primary endpoint in Clarity AD, a phase III validation clinical trial for patients with mild Alzheimer's.

• Alzheimer's disease
• Phase-III
• validation clinical trial

Semaglutide injection is out of stock again in the market for “lying thin”, and it is generally out of stock (socially).

• Semaglutide
• weight loss
• type 2
• diabetes

On September 21, 2022, Pfizer presented the latest clinical data on oral GLP-1 agonists at the EASD2022 meeting.

• GLP-1
• agonist

September 21st is World Alzheimer's Day. The survey report on the awareness and demand of Alzheimer's disease in China was released recently.

• Alzheimer
• FDA
• COSMOS trial

The National Comprehensive Cancer Network (NCCN) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) Guidelines, First Edition 2023, were recently updated.

• Zebutinib
• pharmaceutical industry

On September 8, according to CDE's official website, Kelun Pharmaceuticals submitted a marketing application for Olaparib category 4 generic drugs

• Kelun
• Olaparib
• BRCA
• CDE

On the evening of August 26, the announcement of the results of the 57threview meeting of the GEM Listing Committee in 2022 showed that Hubei HongyuanPharmaceutical Technology Co., Ltd.

• metronidazole
• pharma

Entering August, the market situation of veterinary drug raw materials changed abruptly, the price stagnation was obvious, the market demand recovery was not as good as expected, the downstream purchases were mainly on-demand

• API drug

Recently, Gilead Sciences announced that its novel HIV antiviral capsid inhibitor Lenacapavir (Sunlenca) received marketing authorization from the European Commission (EC) for the treatment

• Capsid inhibitor
• Lenacapavir
• anti AIDS drug

Over the years, APIs have always occupied the highest proportion in my country's export trade of pharmaceutical products. China's API industry also occupies an important position in the global pharmaceutical industry chain.

• API industry

On August 24, Johnson & Johnson/Janssen announced that the European Commission (EC) has granted conditional marketing approval for teclistamab

• BCMA

On August 24, Janssen, a Johnson & Johnson company, announced that the FDA approved the BTK inhibitor ibrutinib (ibrutinib) for the treatment of patients with relapsed/refractory chronic graft-versus-host disease (cGVHD) in children aged 1 year and ol

• cGVHD
• pharmaceutical industry

Many studies on deep-sea fish oil in recent years have found that it does not actually prevent cardiovascular disease. On the one hand, it is because fish oil loses a lot of DHA and EPA during the production process

• HMG-CoA
• statin

On August 24, the National Health Insurance Bureau centrally released its response to the suggestions of the representatives of the Fifth Session of the 13th National People's Congress.

• medical insurance division

On August 25, AstraZeneca announced the approval of three drugs in Japan

• AstraZeneca
• pharmaceutical industry

On August 24, BioMarin Pharmaceutical (BioMarin) announced that the European Commission (EC) has approved the conditional marketing of its hemophilia A gene therapy ROCTAVIAN™ (Valoctocogene Roxaparvovec)

• hemophilia
• BioMarin
• Valoctocogene Roxaparvovec
• gene therapy

High temperature weather occurred in many parts of the country, which had a great impact on the industry. Some enterprises were limited in production and the supply cycle of goods was prolonged.

• veterinary drug
• vitamin
• cephalosporins
• Tetracycline
• peptides